Skip to main content
. 2008 Feb 14;14(6):974–979. doi: 10.3748/wjg.14.974

Table 3.

Treatment, time point of treatment and patient outcome

Case Treatment Time point of treatment after onset (d) Outcome
1 Decreased immunosuppressant; G-CSF; IVIG 16 Death, infection
2 Decreased immunosuppressant; Methylprednisolone 80 mg × 10 d, then taper rapidly; G-CSF; IVIG 6 Death, gastrointestinal bleeding, infection, MOF
3 Decreased immunosuppressant; Methylprednisolone 80 mg × 10 d, then taper rapidly; G-CSF; ATG; IVIG 16 Death, gastrointestinal bleeding, infection, ARDS
4 Decreased immunosuppressant; Methylpredprednisolone impulse treatment, then taper; G-CSF 5 Death, gastrointestinal bleeding, infection, MOF
5 Discontinued immunosuppressant; Methylprednisolone impulse 480 mg/d, then taper; G-CSF; IVIG 6 Death, infection, gastrointestinal bleeding, respiratory failure
6 Non-specific treatment ? Death, infection

G-CSF: Granulocyte colony-stimulating factor; IVIG: Intravenous immunoglobin therapy; MOF: Multiple organ failure; ARDS: Acute respiratory distress syndrome.